AU2003234734A1 - Peptide antagonists of tgf-beta family members and therapeutic uses thereof - Google Patents
Peptide antagonists of tgf-beta family members and therapeutic uses thereofInfo
- Publication number
- AU2003234734A1 AU2003234734A1 AU2003234734A AU2003234734A AU2003234734A1 AU 2003234734 A1 AU2003234734 A1 AU 2003234734A1 AU 2003234734 A AU2003234734 A AU 2003234734A AU 2003234734 A AU2003234734 A AU 2003234734A AU 2003234734 A1 AU2003234734 A1 AU 2003234734A1
- Authority
- AU
- Australia
- Prior art keywords
- tgf
- family members
- therapeutic uses
- peptide antagonists
- beta family
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/07—Tetrapeptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/36011—Togaviridae
- C12N2770/36111—Alphavirus, e.g. Sindbis virus, VEE, EEE, WEE, Semliki
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Toxicology (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13594602A | 2002-04-29 | 2002-04-29 | |
US10/135,946 | 2002-04-29 | ||
PCT/US2003/011437 WO2003093293A2 (en) | 2002-04-29 | 2003-04-15 | Peptide antagonists of tgf-beta family members and therapeutic uses thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2003234734A1 true AU2003234734A1 (en) | 2003-11-17 |
AU2003234734A8 AU2003234734A8 (en) | 2003-11-17 |
Family
ID=29399231
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2003234734A Abandoned AU2003234734A1 (en) | 2002-04-29 | 2003-04-15 | Peptide antagonists of tgf-beta family members and therapeutic uses thereof |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1534737A4 (en) |
AU (1) | AU2003234734A1 (en) |
CA (1) | CA2484994C (en) |
WO (1) | WO2003093293A2 (en) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7723473B2 (en) | 1997-06-19 | 2010-05-25 | St. Louis University | Peptide antagonists of TGF-beta family members and therapeutic uses thereof |
PL1877073T3 (en) * | 2004-12-01 | 2014-03-31 | The Sec Dep For Health | Non-cytotoxic protein conjugates |
US10059756B2 (en) | 2006-11-02 | 2018-08-28 | Acceleron Pharma Inc. | Compositions comprising ALK1-ECD protein |
US8158584B2 (en) | 2008-05-02 | 2012-04-17 | Acceleron Pharma, Inc. | Pharmaceutical preparations comprising an ALK1-Fc fusion protein |
MX2009004718A (en) | 2006-11-02 | 2009-06-19 | Acceleron Pharma Inc | Alk1 receptor and ligand antagonists and uses thereof. |
US8642031B2 (en) | 2006-11-02 | 2014-02-04 | Acceleron Pharma, Inc. | Antagonists of BMP9, BMP10, ALK1 and other ALK1 ligands, and uses thereof |
KR100879239B1 (en) * | 2007-04-19 | 2009-01-16 | (주)케어젠 | Peptide and Its Uses |
WO2009029656A1 (en) | 2007-08-27 | 2009-03-05 | Auxagen, Inc. | METHODS FOR INHIBITING TGF-β |
ES2337973B8 (en) | 2008-05-16 | 2011-07-21 | Proyecto De Biomedicina Cima, S.L. | ADENOVIRUS AUXILIARY SELF-INACTIVANTS FOR THE PRODUCTION OF ADENOVIRUS RECOMBINANTS OF HIGH CAPACITY. |
ES2330826B1 (en) | 2008-06-04 | 2010-07-26 | Proyecto De Biomedicina Cima, S.L. | HIGH CAPACITY ADENOVIRUS PACKING SYSTEM. |
EP2341913B1 (en) | 2008-09-16 | 2014-11-19 | Saint Louis University | Method of enhancing tgf-beta signalling |
WO2010119997A1 (en) * | 2009-04-14 | 2010-10-21 | (주)케어젠 | Peptide having activity of transforming growth factor and production method therefor |
US20120225933A1 (en) | 2009-11-05 | 2012-09-06 | Gonzalez Aseguinolaza Gloria | Regulated expression systems |
WO2012001196A2 (en) | 2010-06-28 | 2012-01-05 | Proyecto De Biomedicina Cima, S.L. | Alphaviral vectors and the uses thereof for heterologous gene expression |
EP2407534A1 (en) | 2010-07-14 | 2012-01-18 | Neo Virnatech, S.L. | Methods and reagents for obtaining transcriptionally active virus-like particles and recombinant virions |
WO2013113755A1 (en) | 2012-01-30 | 2013-08-08 | Fundació Institut D'investigació Biomèdica De Bellvitge (Idibell) | Reagents and methods for the treatment of diseases based on the inhibition of calcineurin - nfat signalling pathway |
ES2523016B1 (en) | 2013-05-20 | 2015-09-09 | 3P Biopharmaceuticals | Alpha-viral vectors and cell lines for the production of recombinant proteins |
EP2878674A1 (en) | 2013-11-28 | 2015-06-03 | Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC) | Stable episomes based on non-integrative lentiviral vectors |
EP3089755A1 (en) | 2014-01-03 | 2016-11-09 | Fundacion Biofisica Bizkaia | VLPs, METHODS FOR THEIR OBTENTION AND APPLICATIONS THEREOF |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4423037A (en) * | 1982-05-13 | 1983-12-27 | The General Hospital Corporation | Inhibitors of peptide hormone action |
US5571714A (en) * | 1988-12-22 | 1996-11-05 | Celtrix Pharmaceuticals, Inc. | Monoclonal antibodies which bind both transforming growth factors β1 and β2 and methods of use |
ES2146552B1 (en) * | 1998-11-24 | 2001-04-16 | Inst Cientifico Tecnol Navarra | INHIBITING PEPTIDES OF TGF / 31 |
-
2003
- 2003-04-15 CA CA2484994A patent/CA2484994C/en not_active Expired - Lifetime
- 2003-04-15 AU AU2003234734A patent/AU2003234734A1/en not_active Abandoned
- 2003-04-15 WO PCT/US2003/011437 patent/WO2003093293A2/en not_active Application Discontinuation
- 2003-04-15 EP EP03728390A patent/EP1534737A4/en not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
WO2003093293A2 (en) | 2003-11-13 |
WO2003093293A3 (en) | 2005-04-07 |
CA2484994A1 (en) | 2003-11-13 |
CA2484994C (en) | 2016-06-14 |
AU2003234734A8 (en) | 2003-11-17 |
EP1534737A4 (en) | 2007-10-31 |
EP1534737A2 (en) | 2005-06-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2003234734A1 (en) | Peptide antagonists of tgf-beta family members and therapeutic uses thereof | |
EP1636250A4 (en) | Self-assembling peptides incorporating modifications and methods of use thereof | |
AU2003254844A1 (en) | Substituted amino compounds and use thereof | |
AU2003279912A1 (en) | Peptide rod amphiphiles and self-assembly of same | |
AU2003267532A1 (en) | PEPTIDES AND PEPTIDE DERIVATIVES FOR THE TREATMENT OF Alpha-SYNUCLEIN-RELATED DISEASES | |
AU2003279841A1 (en) | Uses of human zven antagonists | |
AU2003232077A1 (en) | Cyclic peptide anti-cancer agents and methods | |
AU2003231980A1 (en) | Identification of apoptotic peptides and methods of use thereof | |
AU2003246614A1 (en) | Novel use of lipopeptide preparations | |
PL361364A1 (en) | Peptide and pharmaceutical composition as well as their therapeutic applications | |
AU2002230129A1 (en) | Novel physiologically active peptide and use thereof | |
AU2003284597A1 (en) | Apoptosis-associated protein and use thereof | |
AU2003275948A1 (en) | Pharmaceutical composition comprising a tissue factor antagonist and protein c polypeptides | |
AU2003256289A1 (en) | Modified shine-dalgarno sequences and methods of use thereof | |
AU2003218232A1 (en) | Peptide analogues and uses thereof | |
AUPR595601A0 (en) | Hypoglycaemic peptides and methods of use thereof | |
AU2003220085A1 (en) | Protein a compositions and methods of use | |
AU2003228610A1 (en) | Thyrotropin-releasing hormone analogues and their therapeutic applications | |
AU2003280992A1 (en) | Novel proteins and use thereof | |
AU2003292774A1 (en) | Novel proteins and use thereof | |
AU2003261900A1 (en) | Method of designing physiologically active peptide and use thereof | |
AU2002953561A0 (en) | Peptides and therapeutic uses thereof | |
AUPS243002A0 (en) | Therapeutic target and uses thereof | |
AU2003235665A1 (en) | Diagnostic and therapeutic uses of topors | |
AU2003234948A1 (en) | Peptide having an immunoregulatory property and the composition of said peptide |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |